What is VRTX stock price today?

VRTX (Vertex Pharmaceuticals Inc) stock is trading at $481.65 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is VRTX stock going up or down today?

VRTX stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy VRTX stock now?

The decision to buy VRTX depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is VRTX a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for VRTX based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is VRTX stock overvalued or undervalued?

VRTX currently trades at a P/E ratio of 29.67, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if VRTX is fairly priced.

What is VRTX's P/E ratio?

VRTX has a price-to-earnings (P/E) ratio of 29.67, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is VRTX's market cap?

VRTX (Vertex Pharmaceuticals Inc) has a market capitalization of $106.87 billion, making it a mid-cap stock.

What is VRTX's price to book ratio?

Price-to-book ratio for VRTX is available on our dashboard along with other valuation metrics.

Does VRTX pay dividends?

VRTX does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is VRTX's dividend yield?

VRTX does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is VRTX stock a good long-term investment?

VRTX's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is VRTX's revenue growth rate?

Revenue growth data for VRTX is available on our dashboard with detailed financial statement analysis.

Profitability metrics for VRTX are available on our dashboard with complete income statement analysis.

What are the risks of investing in VRTX?

Key risks for VRTX include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does VRTX compare to its competitors?

Compare VRTX to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize VRTX's performance and positioning.

What is VRTX's stock price target for 2026?

Our AI model provides price targets for VRTX based on fundamental analysis: Bull case $626.15 (+30%), Base case $553.90 (+15%), Bear case $433.49 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about VRTX?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for VRTX. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is VRTX's next earnings report?

VRTX reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

VRTX - Vertex Pharmaceuticals Inc

NYSE * Healthcare * Biotechnology

$481.65

$-3.74 (-0.77%)

About Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Inc (VRTX) common stock

Price Chart

Loading chart...

VRTX Key Statistics

Market Cap

$106.87B

P/E Ratio

29.67

How VRTX Compares to Peers

VRTX trades at a premium valuation vs peers (highest P/E)

P/E Rank

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
VRTX(This stock)	$106.87B	29.7	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB
MRNAModerna Inc	$24.52B	N/A	0%	0.0%	vs MRNA

Data Updated: July 13, 2026 at 7:28 PM EDT

Ready to invest in VRTX?

Commission-free trading available. Affiliate links.

VRTX Lician Score

14% confidence

4.0/10

Neutral

VRTX has a Lician Score of 4/10 (Average). Areas of concern: Growth.

value

5.0

growth

2.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates VRTXacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

VRTX Financial Snowflake

5-axis analysis across key investment dimensions

4.4/10

Neutral

5.0

Value

Valuation vs. sector peers

2.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for VRTX

Dashboard

Enter a ticker to analyze